Current Report Filing (8-k)
October 09 2015 - 6:03AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): October 7, 2015
DAVITA HEALTHCARE PARTNERS INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
1-14106 |
|
No. 51-0354549 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
2000 16th Street
Denver, CO 80202
(Address
of principal executive offices including Zip Code)
(303) 405-2100
(Registrants telephone number, including area code)
Not applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On October 7, 2015, the Board of Directors (the Board) of DaVita HealthCare Partners Inc. (the Company) appointed
Barbara J. Desoer, as a member of the Board.
Ms. Desoer will receive the standard compensation and indemnification applicable to all
other non-employee directors. We have described our non-employee director compensation policy in our Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the SEC) on April 30, 2015. The form of
indemnification agreement we entered into with Ms. Desoer is an exhibit to our Current Report on Form 8-K filed with the SEC on December 20, 2006.
No arrangement or understanding exists between Ms. Desoer and any other person or persons pursuant to which she was selected as a
director. The Company has not been a participant in any transaction since the beginning of its last fiscal year, and is not a participant in any currently proposed transaction, in which Ms. Desoer, or any member of her immediate family, had or
will have a direct or indirect material interest.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
DAVITA HEALTHCARE PARTNERS INC. |
|
|
|
Date: October 9, 2015 |
|
|
|
/s/ Kim M. Rivera |
|
|
|
|
Kim M. Rivera |
|
|
|
|
Chief Legal Officer |
DaVita (NYSE:DVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Apr 2023 to Apr 2024